Postgraduate Program in Pathology, Institute of Biological Sciences of the Federal University of Minas Gerais, Brazil; Department of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil.
Department of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Brazil.
Acta Trop. 2021 Dec;224:106114. doi: 10.1016/j.actatropica.2021.106114. Epub 2021 Aug 24.
Amoebiasis is a protozoan disease caused by Entamoeba histolytica, and presents a geographic distribution of worldwide amplitude, high incidence, sometimes accompanied by severe clinical manifestations such as amoebic colitis and Amoebic Liver Abscess (ALA), remaining as a public health problem in developing countries. Entamoeba dispar is another species of amoeba that infects approximately 12% of the world's population, and it has previously been classified as noninvasive. However, E. dispar has already been isolated from patients with symptomatic non-dysenteric colitis, as well as its DNA sequences were detected and genotyped in samples from patients with dysenteric colitis, and patients with ALA, suggesting that this species could also be involved in the development of lesions in the large intestine and liver of human beings. In this context, this study aims to evaluate the ability of isolated strains of Entamoeba dispar in South America to cause liver damage, and to better characterize histopathological findings in 3, 8, 12 and 16 days after infection (DAI). Firstly, we assessed whether trophozoites from MCR, ACFN, ICS, ADO and VEJ E. dispar strains, and EGG Entamoeba histolytica strain differed in their in vitro phagocytosis ability, being related to greater ability to phagocyte with greater virulence. Then, we investigate and characterize histopathological changes present in the liver of mice induced by different strains of E. dispar. Our results demonstrated that trophozoites from E. dispar strains are capable of phagocyting human erythrocytes, but in lower amounts than Entamoeba histolytica. In addition, we described and characterized the lesions in different periods after infection by different E. dispar strains, and identified ACFN as the most pathogenic strain, followed by MCR. The large areas of necrosis produced by the ACFN strain as the eighth DAI, which also show high parasitism, led to 100% mortality. On the other hand, the ICS, ADO and VEJ strains did not produce mortality, and this was correlated with the presence of well-developed chronic granulomatous inflammation, necrosis absorption throughout the infection, and regeneration of the liver parenchyma. The greater pathogenicity of the ACFN strain strongly suggests that this strain could be producing higher levels of virulence factors. As the experimental infection, the heterogeneity of biological behavior of different Entamoeba dispar strains could be involved in the development of undiagnosed human clinical conditions.
阿米巴病是由溶组织内阿米巴原虫引起的原虫病,具有全球分布范围广、发病率高的特点,有时伴有严重的临床表现,如阿米巴结肠炎和肝脓肿(ALA),在发展中国家仍是一个公共卫生问题。迪斯帕阿米巴原虫是另一种感染全世界约 12%人口的阿米巴原虫,以前被归类为非侵袭性。然而,迪斯帕阿米巴原虫已从有症状的非痢疾性结肠炎患者中分离出来,其 DNA 序列也在痢疾性结肠炎患者和 ALA 患者的样本中被检测和基因分型,这表明该物种也可能参与人类大肠和肝脏损伤的发展。在这种情况下,本研究旨在评估南美的分离株迪斯帕阿米巴原虫引起肝损伤的能力,并更好地描述感染后 3、8、12 和 16 天(DAI)的组织病理学发现。首先,我们评估了来自 MCR、ACFN、ICS、ADO 和 VEJ 迪斯帕阿米巴原虫株和 EGG 溶组织内阿米巴原虫株的滋养体在体外吞噬能力方面是否存在差异,这与更强的吞噬能力和更高的毒力有关。然后,我们研究并描述了不同迪斯帕阿米巴原虫株感染引起的小鼠肝脏的组织病理学变化。我们的结果表明,迪斯帕阿米巴原虫株的滋养体能够吞噬人红细胞,但数量少于溶组织内阿米巴原虫。此外,我们描述并表征了不同迪斯帕阿米巴原虫株在不同时期感染后的病变,并确定 ACFN 株是最具致病性的,其次是 MCR 株。ACFN 株在第 8 天产生的大面积坏死,以及高寄生虫感染率,导致 100%的死亡率。另一方面,ICS、ADO 和 VEJ 株不会导致死亡,这与成熟的慢性肉芽肿性炎症的存在、感染过程中坏死的吸收以及肝实质的再生有关。ACFN 株的高致病性强烈表明该菌株可能产生更高水平的毒力因子。在实验感染中,不同迪斯帕阿米巴原虫株的生物学行为的异质性可能与未诊断的人类临床情况的发展有关。